Trials / Recruiting
RecruitingNCT06885918
ALS Research Collaborative
ALS Translational Research Program
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- ALS Therapy Development Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.
Conditions
- Amyotrophic Lateral Sclerosis
- ALS (Amyotrophic Lateral Sclerosis)
- ALS With Frontotemporal Dementia (ALS/FTD)
- Motor Neuron Disease
- Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Timeline
- Start date
- 2014-09-12
- Primary completion
- 2035-01-31
- Completion
- 2035-01-31
- First posted
- 2025-03-20
- Last updated
- 2025-03-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06885918. Inclusion in this directory is not an endorsement.